These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Dölle C; Flønes I; Nido GS; Miletic H; Osuagwu N; Kristoffersen S; Lilleng PK; Larsen JP; Tysnes OB; Haugarvoll K; Bindoff LA; Tzoulis C Nat Commun; 2016 Nov; 7():13548. PubMed ID: 27874000 [TBL] [Abstract][Full Text] [Related]
8. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Simon DK; Lin MT; Zheng L; Liu GJ; Ahn CH; Kim LM; Mauck WM; Twu F; Beal MF; Johns DR Neurobiol Aging; 2004 Jan; 25(1):71-81. PubMed ID: 14675733 [TBL] [Abstract][Full Text] [Related]
9. Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat. Parkinson GM; Dayas CV; Smith DW Curr Aging Sci; 2014; 7(3):155-60. PubMed ID: 25612740 [TBL] [Abstract][Full Text] [Related]
10. Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues. Chen C; Vincent AE; Blain AP; Smith AL; Turnbull DM; Reeve AK Neurobiol Dis; 2020 Feb; 134():104631. PubMed ID: 31689514 [TBL] [Abstract][Full Text] [Related]
11. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease. Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521 [TBL] [Abstract][Full Text] [Related]
12. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders. Palin EJ; Paetau A; Suomalainen A Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324 [TBL] [Abstract][Full Text] [Related]
13. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism. Song L; McMackin M; Nguyen A; Cortopassi G Neurobiol Dis; 2017 Apr; 100():30-38. PubMed ID: 28042097 [TBL] [Abstract][Full Text] [Related]
14. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Luoma P; Melberg A; Rinne JO; Kaukonen JA; Nupponen NN; Chalmers RM; Oldfors A; Rautakorpi I; Peltonen L; Majamaa K; Somer H; Suomalainen A Lancet; 2004 Sep 4-10; 364(9437):875-82. PubMed ID: 15351195 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742 [TBL] [Abstract][Full Text] [Related]
16. Somatic mitochondrial DNA mutations do not increase neuronal vulnerability to MPTP in young POLG mutator mice. Dai Y; Clark J; Zheng K; Kujoth GC; Prolla TA; Simon DK Neurotoxicol Teratol; 2014; 46():62-7. PubMed ID: 25450660 [TBL] [Abstract][Full Text] [Related]
17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
20. Testosterone Upregulates the Expression of Mitochondrial ND1 and ND4 and Alleviates the Oxidative Damage to the Nigrostriatal Dopaminergic System in Orchiectomized Rats. Yan W; Kang Y; Ji X; Li S; Li Y; Zhang G; Cui H; Shi G Oxid Med Cell Longev; 2017; 2017():1202459. PubMed ID: 29138672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]